Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Partners for Growth
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
Legal entity Pty Ltd its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Light Horse is a small molecule drug discovery company that is leading the way in a.
Terray TherapeuticsSeries B $120M · 23 mo ago • 51-200 employees • 3 roles
The only integrated full-stack AI platform for small molecule drug discovery.
Metanova Labs is an AI drug discovery company building a new model for discovering and developing novel therapeutics. Through NOVA, its…
Alloy TherapeuticsSeries E $40M · 5 mo ago • 51-200 employees • 8 roles
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…
MOLCUREFounded 2019 • 11-50 employees • 1 role
Molcure Inc. is an AI company focusing on accelerating drug discovery through the combination machine learning, biotechnology, and robotics.
Advanced 3D and multi-tissue biology for predictive drug discovery. Ready-to-use microtissues for efficacy, safety, DMPK-Tox & biomarker…

Overview

SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.

News

Blog 3 years ago
Viva Biotech's 2023 Overseas Appreciation Receptions Prove to be a Great Success Again
Viva Biotech's 2023 Overseas Appreciation Receptions Prove to be a Great Success Again #generic_content-block_7fcac4113c5f4bc369ec69d9eb20e1ea { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #generic_content-b
Read more
Report
Blog 3 years ago
SYNthesis med chem, Cytopia and Ojjaara
SYNthesis med chem, Cytopia and Ojjaara #generic_content-block_52a10da861b0e6a66a1c15202df0b4dc { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #generic_content-block_52a10da861b0e6a66a1c15202df0b4dc { padding
Read more
Report
Blog 3 years ago
SYNthesis med chem supporting a variety of Drug Discovery events through the end of 2023 and into 2024
SYNthesis med chem supporting a variety of Drug Discovery events through the end of 2023 and into 2024 #generic_content-block_c6249dcb1c404794d98b2076e2ac2413 { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #g
Read more
Report
Blog 3 years ago
SYNthesis med chem, Viva Biotech providing innovation and support to Targeted Protein Degradation (TPD) Drug Discovery projects
SYNthesis med chem, Viva Biotech providing innovation and support to Targeted Protein Degradation (TPD) Drug Discovery projects #generic_content-block_869cd23acd64c642daada374161eea17 { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px)
Read more
Report
Blog 3 years ago
SYNthesis med chem joins Lean Life Science's Oncology Development Programme (ODP2)
SYNthesis med chem joins Lean Life Science's Oncology Development Programme (ODP2) #generic_content-block_390382597e16e5e093ffce66651d5401 { padding-top: 30px; padding-bottom: 30px; } @media (max-width: 818px) and (min-width: 0px) { #generic_content-block
Read more
Report